Ocuphire Pharma, Inc.(OCUP)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OCUP Ocuphire Pharma, Inc.

交易中 12-19 13:26:46 EST

1.17

+0.00

0.00%

最高1.17	最低1.17	成交量0.00
今开1.17	昨收1.17	日振幅0.00%
总市值3,065万	流通市值2,869万	总股本2,620万
成交额79.30万	换手率0.00%	流通股本2,452万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OCUP","market":"US","secType":"STK","nameCN":"Ocuphire Pharma, Inc.","latestPrice":1.17,"timestamp":1729713600000,"preClose":1.17,"halted":8,"volume":0,"delay":0,"floatShares":24519364,"shares":26198444,"eps":-0.595078,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"12-19 13:26:46 EST","open":1.17,"high":1.17,"low":1.17,"amount":793045.150703,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.595078,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734642000000},"symbolChange":{"newSymbol":"IRD","executeDate":"2024-10-24"},"adr":0,"listingDate":1100235600000,"adjPreClose":1.17,"volumeRatio":0},"requestUrl":"/m/hq/s/OCUP","defaultTab":"news","newsList":[{"id":"2477454535","title":"Ocuphire Pharma, Inc.盘中异动 早盘急速下挫5.26%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477454535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477454535?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:03","pubTimestamp":1729692196,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日22时03分，Ocuphire Pharma, Inc.股票出现波动，股价大幅下跌5.26%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.38%。其相关个股中，Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Virax Biolabs Group Limited涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1442.80%、752.36%、328.27%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Tevogen Bio Holdings Inc.，振幅分别为71.86%、62.96%、58.39%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023220316a1e410d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023220316a1e410d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUP"],"gpt_icon":0},{"id":"2473487020","title":"Ocuphire Pharma, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473487020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473487020?lang=zh_cn&edition=full","pubTime":"2024-10-08 02:55","pubTimestamp":1728327351,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日02时55分，Ocuphire Pharma, Inc.股票出现异动，股价快速下跌5.30%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Scholar Rock Holding Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Celularity Inc C/Wts 16/07/2026 涨幅较大，Aditxt, Inc.、Tc Biopharm  Plc、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1655.34%、90.01%、60.66%，振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Akari Therapeutics Plc，振幅分别为107.82%、39.46%、37.93%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008025551a1deb498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008025551a1deb498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUP"],"gpt_icon":0},{"id":"2472571019","title":"Ocuphire Pharma, Inc.盘中异动 下午盘急速上涨5.49%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472571019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472571019?lang=zh_cn&edition=full","pubTime":"2024-10-03 01:17","pubTimestamp":1727889421,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日01时17分，Ocuphire Pharma, Inc.股票出现波动，股价大幅上涨5.49%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.00%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100301170198e3a3f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100301170198e3a3f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2470263380","title":"Ocuphire Pharma, Inc.盘中异动 大幅下挫5.11%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470263380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470263380?lang=zh_cn&edition=full","pubTime":"2024-09-25 22:08","pubTimestamp":1727273289,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日22时08分，Ocuphire Pharma, Inc.股票出现波动，股价急速下挫5.11%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.22%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925220810ab65ea01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925220810ab65ea01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2469214675","title":"Ocuphire Pharma, Inc.盘中异动 大幅下挫5.15%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469214675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469214675?lang=zh_cn&edition=full","pubTime":"2024-09-21 00:06","pubTimestamp":1726848401,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日00时06分，Ocuphire Pharma, Inc.股票出现异动，股价急速下跌5.15%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为2.21%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921000641ab64e92f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921000641ab64e92f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2468750518","title":"Ocuphire Pharma, Inc.盘中异动 急速上涨6.02%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468750518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468750518?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:37","pubTimestamp":1726756651,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时37分，Ocuphire Pharma, Inc.股票出现波动，股价快速拉升6.02%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.20%。其相关个股中，Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Edgewise Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为3745.88%、649.07%、158.78%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为81.66%、78.69%、52.97%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192237329719be00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192237329719be00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUP"],"gpt_icon":0},{"id":"2461839430","title":"Ocuphire Pharma, Inc.盘中异动 临近收盘股价大跌5.15%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461839430","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461839430?lang=zh_cn&edition=full","pubTime":"2024-08-21 03:42","pubTimestamp":1724182922,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日03时42分，Ocuphire Pharma, Inc.股票出现波动，股价大幅下跌5.15%。截至发稿，该股报1.29美元/股，成交量25.4918万股，换手率0.97%，振幅7.35%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821034203a1d53ff4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821034203a1d53ff4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2460032552","title":"Ocuphire Pharma, Inc.盘中异动 早盘股价大涨5.26%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460032552","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460032552?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:45","pubTimestamp":1724075144,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时45分，Ocuphire Pharma, Inc.股票出现波动，股价大幅拉升5.26%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921454498e3559b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921454498e3559b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2460212736","title":"Ocuphire Pharma, Inc.2024财年第二财季实现净利润-7.77百万美元，同比减少56.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460212736","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460212736?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910664,"startTime":"0","endTime":"0","summary":"8月18日，Ocuphire Pharma, Inc.公布财报，公告显示公司2024财年第二财季净利润为-7.77百万美元，同比减少56.65%；其中营业收入为1.11百万美元，同比减少69.75%，每股基本收益为-0.30美元。从资产负债表来看，Ocuphire Pharma, Inc.总负债4.20百万美元，其中短期债务0.00美元，资产负债比为10.68，流动比率为10.68。机构评级：截至2024年8月18日，当前有4家机构对Ocuphire Pharma, Inc.目标价做出预测，其中目标均价为16.75美元，其中最低目标价为11.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800065095a167f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800065095a167f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP"],"gpt_icon":0},{"id":"2459347336","title":"Ocuphire Pharma, Inc.盘中异动 早盘股价大跌5.60%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459347336","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459347336?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:45","pubTimestamp":1723729517,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时45分，Ocuphire Pharma, Inc.股票出现异动，股价快速跳水5.60%。截至发稿，该股报1.18美元/股，成交量10.8539万股，换手率0.41%，振幅7.20%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815214517ab5dd8ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815214517ab5dd8ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2459174322","title":"Ocuphire Pharma, Inc.盘中异动 大幅上涨6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459174322","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459174322?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:30","pubTimestamp":1723642242,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时30分，Ocuphire Pharma, Inc.股票出现波动，股价急速上涨6.10%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Conduit Pharmaceuticals Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Viracta Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为48.76%、42.19%、18.13%，振幅较大的相关个股有Cadrenal Therapeutics, Inc.、Verrica制药、Acelyrin, Inc.，振幅分别为7.86%、7.78%、6.93%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081421304398e34ecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081421304398e34ecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2459906025","title":"Ocuphire Pharma, Inc.盘中异动 大幅下跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459906025","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459906025?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:32","pubTimestamp":1723555926,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时32分，Ocuphire Pharma, Inc.股票出现异动，股价大幅跳水6.34%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321320694200445&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321320694200445&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2459031269","title":"Ocuphire Pharma Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459031269","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459031269?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:00","pubTimestamp":1723554024,"startTime":"0","endTime":"0","summary":"   * Ocuphire Pharma Inc   报告，截至6月底的季度调整后每股亏损30美分，低于去年同期的每股收益-24美分。四位分析师对该季度的平均预期是每股亏损 25 美分。华尔街预期为每股-31美分至-14美分。* 营收同比下降 69.7%，为 111 万美元；分析师预期为 246 万美元。* Ocuphire Pharma Inc公布的本季度每股收益为亏损30美分。* Ocuphire Pharma Inc本季度股价上涨了8.2%，今年迄今为止亏损了45.0%。华尔街对 Ocuphire Pharma Inc 的 12 个月目标价中位数为 19.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Ocuphire Pharma Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2458235543","title":"Ocuphire Pharma, Inc.盘中异动 下午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458235543","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458235543?lang=zh_cn&edition=full","pubTime":"2024-08-10 03:04","pubTimestamp":1723230263,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日03时04分，Ocuphire Pharma, Inc.股票出现异动，股价大幅下跌5.07%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为2.43%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810030423aefe2abf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810030423aefe2abf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUP"],"gpt_icon":0},{"id":"2457031275","title":"Ocuphire Pharma, Inc.盘中异动 快速拉升5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457031275","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457031275?lang=zh_cn&edition=full","pubTime":"2024-08-08 22:27","pubTimestamp":1723127232,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日22时27分，Ocuphire Pharma, Inc.股票出现异动，股价快速上涨5.85%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为2.22%。其相关个股中，Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Exscientia Plc涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃，换手率分别为297.14%、268.96%、170.54%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Entero Therapeutics Inc.，振幅分别为74.12%、50.70%、35.28%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808222712af96a0a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808222712af96a0a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2457823094","title":"Ocuphire Pharma Inc    预计每股亏损 24 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457823094","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457823094?lang=zh_cn&edition=full","pubTime":"2024-08-07 23:22","pubTimestamp":1723044160,"startTime":"0","endTime":"0","summary":"   * Ocuphire Pharma Inc    预计将在8月9日公布截至2024年6月30日的业绩报告时显示季度收入下降(预计)    * 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于密歇根州法明顿希尔斯的公司的营收将从去年同期的367万美元降至261.3万美元，降幅为28.9%。* LSEG 分析师对 Ocuphire Pharma Inc 的平均预期是每股亏损 24 美分。* 华尔街对 Ocuphire Pharma Inc 的 12 个月目标价中位数为 19.00 美元，高于其最新收盘价 1.72 美元。8月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Ocuphire Pharma Inc    预计每股亏损 24 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUP"],"gpt_icon":0},{"id":"2457443720","title":"Ocuphire Pharma, Inc.盘中异动 早盘急速跳水6.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457443720","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457443720?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:33","pubTimestamp":1722864807,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时33分，Ocuphire Pharma, Inc.股票出现异动，股价快速下跌6.70%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。其相关个股中，Zevra Therapeutics, Inc.、Okyo Pharma Ltd Com Npv 、Pasithea Therapeutics Corp.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为995.74%、37.04%、13.57%，振幅较大的相关个股有Vor Biopharma Inc.、Compass Therapeutics, Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为13.04%、12.65%、12.03%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052133279f106fbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052133279f106fbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2456645679","title":"Ocuphire Pharma, Inc.盘中异动 股价大跌7.54%报1.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456645679","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456645679?lang=zh_cn&edition=full","pubTime":"2024-08-02 00:49","pubTimestamp":1722530963,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日00时49分，Ocuphire Pharma, Inc.股票出现波动，股价大幅下挫7.54%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Dermata Therapeutics Inc C/Wts 涨幅较大，Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃，换手率分别为1820.95%、346.37%、211.59%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Virax Biolabs Group Limited、Biomea Fusion, Inc.，振幅分别为57.55%、43.37%、43.27%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802004923aefcbb05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802004923aefcbb05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2455969980","title":"Ocuphire Pharma, Inc.盘中异动 下午盘快速下挫5.31%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455969980","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455969980?lang=zh_cn&edition=full","pubTime":"2024-07-31 01:23","pubTimestamp":1722360228,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日01时23分，Ocuphire Pharma, Inc.股票出现波动，股价快速下挫5.31%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Imunon, Inc.、Celularity Inc C/Wts 16/07/2026 、Processa Pharmaceuticals, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为1929.11%、1515.22%、1265.16%，振幅较大的相关个股有Imunon, Inc.、Cns Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.，振幅分别为78.15%、59.59%、58.82%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731012348941fbfab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731012348941fbfab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2453905249","title":"Ocuphire Pharma, Inc.盘中异动 股价大涨5.37%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453905249","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453905249?lang=zh_cn&edition=full","pubTime":"2024-07-24 00:06","pubTimestamp":1721750779,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日00时06分，Ocuphire Pharma, Inc.股票出现异动，股价大幅拉升5.37%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.10%。其相关个股中，Azitra Inc、Salarius Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc涨幅较大，Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc较为活跃，换手率分别为7394.06%、5546.44%、3461.07%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc，振幅分别为366.13%、365.43%、137.74%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724000620af93ae1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724000620af93ae1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocuphire.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.1959},{"period":"6month","weight":-0.2595},{"period":"1year","weight":-0.5585},{"period":"ytd","weight":-0.6113}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ocuphire Pharma, Inc.是一家临床阶段的眼科生物制药公司，致力于开发和商业化用于治疗多种眼疾的疗法。Ocuphire的产品线目前包括针对眼部适应症的两种小分子候选产品。该公司的主要产品候选产品Nyxol眼药水是一种每日一次无防腐剂的甲磺酸酚妥拉明的眼药水配方，一种非选择性的α-1和α-2肾上腺素能拮抗剂，旨在减少瞳孔大小，目前正在开发有几种适应症，包括昏暗的灯光或夜视障碍，药理性散瞳和老花眼。Ocuphire的第二个候选产品APX3330是每天两次的口服片剂，旨在抑制与视网膜和脉络膜血管疾病（例如糖尿病性视网膜病变和糖尿病性黄斑水肿）相关的血管生成和炎症途径。","yearOnYearQuotes":[{"month":1,"riseRate":0.45,"avgChangeRate":0.081272},{"month":2,"riseRate":0.5,"avgChangeRate":0.063536},{"month":3,"riseRate":0.35,"avgChangeRate":0.008391},{"month":4,"riseRate":0.421053,"avgChangeRate":0.546155},{"month":5,"riseRate":0.6,"avgChangeRate":4.57464},{"month":6,"riseRate":0.4,"avgChangeRate":-0.017062},{"month":7,"riseRate":0.35,"avgChangeRate":-0.003257},{"month":8,"riseRate":0.35,"avgChangeRate":-0.024514},{"month":9,"riseRate":0.45,"avgChangeRate":-0.02299},{"month":10,"riseRate":0.25,"avgChangeRate":-0.107241},{"month":11,"riseRate":0.315789,"avgChangeRate":-0.064728},{"month":12,"riseRate":0.45,"avgChangeRate":0.058972}],"exchange":"NASDAQ","name":"Ocuphire Pharma, Inc.","nameEN":"Ocuphire Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ocuphire Pharma, Inc.(OCUP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ocuphire Pharma, Inc.(OCUP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ocuphire Pharma, Inc.,OCUP,Ocuphire Pharma, Inc.股票,Ocuphire Pharma, Inc.股票老虎,Ocuphire Pharma, Inc.股票老虎国际,Ocuphire Pharma, Inc.行情,Ocuphire Pharma, Inc.股票行情,Ocuphire Pharma, Inc.股价,Ocuphire Pharma, Inc.股市,Ocuphire Pharma, Inc.股票价格,Ocuphire Pharma, Inc.股票交易,Ocuphire Pharma, Inc.股票购买,Ocuphire Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ocuphire Pharma, Inc.(OCUP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ocuphire Pharma, Inc.(OCUP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况